Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6189793 | Brachytherapy | 2013 | 13 Pages |
Abstract
The American Brachytherapy Society-recommended tumor margin may be inadequate for prescription dose coverage given COMS plaque radiation characteristics and placement uncertainties. Better coverage is achieved assuming a GTV-to-planning target volume total basal expansion of 3Â mm or greater and/or prescribing beyond the tumor apex.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nolan L. Gagne, Mark J. Rivard,